Predicting dementia: Role of dementia risk indices

Assistant Professor of Psychiatry, University of California, San Francisco, San Francisco VA Medical Center, 4150 Clement Street, 151R, San Francisco, CA 94121, USA.
Future Neurology 09/2009; 4(5):555-560. DOI: 10.2217/fnl.09.43
Source: PubMed

ABSTRACT There are currently more than 5 million people in the USA living with Alzheimer's disease and other forms of dementia, and prevalence is expected to triple over the next 40 years. As new strategies for prevention and treatment are developed, it will be critically important to be able to identify older adults who do not currently have dementia but have a high risk of developing symptoms within a few years so that they can be targeted for monitoring, prevention and early treatment. In other fields, prognostic models and risk indices are often used to identify high-risk individuals (e.g., Framingham Heart Index and Breast Cancer Risk Assessment Tool). The objective of this paper is to describe the development of Dementia Risk Indices and to discuss the potential for these tools to be incorporated into clinical and research settings for the identification of individuals with a high risk of dementia.

Download full-text


Available from: Deborah Barnes, Nov 15, 2014
6 Reads
  • Source
    Alzheimer's & dementia: the journal of the Alzheimer's Association 03/2010; 6(2):138-41. DOI:10.1016/j.jalz.2010.01.005 · 12.41 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We argue that age is a descriptive, and not explanatory, variable and consequently cannot account for the cognitive changes that often occur with aging. Once age is removed from consideration, other truly causal explanations for "cognitive aging" must be identified. We argue that health and disease represent an important class of explanatory variables for age-related cognitive changes. We make this argument first by reviewing the prevalence of risk factors, disability, and subclinical and frank disease in the elderly population. We emphasize that the complexity of health effects rivals that of age on cognition while noting that most studies of cognitive aging rarely consider this complexity fully. We then consider in more detail the "vascular hypothesis," which proposes that vascular diseases (e.g., stroke, heart disease) and their risk factors (e.g., hypertension) can explain aspects of cognitive decline in aging through their impact on circulatory and brain functions. Clinical implications of this hypothesis suggest that treatment of vascular risk factors might well reduce the incidence or severity of dementia syndromes. We conclude with a brief summary of approaches to further integrate aspects of health and disease into the study of "cognitive aging."
    The Journals of Gerontology Series B Psychological Sciences and Social Sciences 07/2011; 66 Suppl 1:i17-25. DOI:10.1093/geronb/gbr018 · 3.21 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Alzheimer's disease (AD) is a highly disabling progressive neurodegenerative disorder characterized by a steadily growing number of patients, by the absence of a cure for the disease and by great difficulties in diagnosing in the preclinical phase. Progresses in defining the complex etiopathogenesis of AD consider oxidative stress a core aspect as far as both AD onset and progression are concerned. However, clinical trials of antioxidants in AD have brought conflicting conclusions. In this review, we report the main results of clinical trials with antioxidants in mild cognitive impairment (MCI) and AD. Although available data do not warrant the doubtless use of antioxidants in AD, they are characterized by extremely poor comparability and the absence of a substantial clinical benefit of antioxidants in AD is not disproved to date. Furthermore, the role of vascular damage that contributes to oxidative stress in AD should be addressed in testing antioxidant treatments. This article is part of a Special Issue entitled: Antioxidants and Antioxidant Treatment in Disease.
    Biochimica et Biophysica Acta 10/2011; 1822(5):631-8. DOI:10.1016/j.bbadis.2011.10.006 · 4.66 Impact Factor
Show more